What is the Astonea Labs Ltd share price today?

The share price of BSE:ASTONEALAB-M on 01 Oct 2026 (as of 15:05:30 IST) is ₹345.

What is the BSE:ASTONEALAB-M 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:ASTONEALAB-M 52 week high low range shows a high of ₹369 and a low of ₹118.

What is the Astonea Labs Ltd market cap?

As on 01 Oct 2026, Astonea Labs Ltd market cap is ₹3659400000.

What is the shareholding pattern of Astonea Labs Ltd Stock?

The shareholding pattern of Astonea Labs Ltd, as of last reported-on 31 Mar 2026 is: Promoters: 72.3% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0.07% Mutual Funds: 0% Retail & Others: 27.63% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Astonea Labs Ltd?

The Price-to-Earnings (PE) ratio of Astonea Labs Ltd is 81.0463, and the Price-to-Book (PB) ratio is 2.8167, as on 01 Oct 2026.

Astonea Labs Share Price

330.00+0.00 (-2.94%)

+112.70% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.94%

1 Week

-2.94%

1 Month

-1.49%

3 Month

+22.22%

6 Month

+91.86%

YTD

+101.83%

1 Year

+112.70%

5 Year

10 Year

Max

+140.09%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

330.00

316.35

257.00

165.05

118.00

High

330.00

340.00

369.00

About

Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

ASTONEALAB-MNSE

LTP

1W Low

1W High

Market cap (₹)

1793+14.75 (0.83%)

1720.80

1809.65

4,25,150Cr

10042.95+327.95 (3.38%)

9866.35

10080.20

2,66,265Cr

4670+34.85 (0.75%)

4555

4682

1,76,301Cr

2330.9-61.1 (-2.55%)

2252.50

2442

1,25,352Cr

1263.85+19.85 (1.60%)

1217.70

1266.15

1,23,591Cr

1364.95+14.75 (1.09%)

1337.30

1390.70

1,14,351Cr

1398.75+18.75 (1.36%)

1364.75

1400.60

1,12,474Cr

2487.4-1.35 (-0.05%)

2457.35

2523.70

1,02,315Cr

1708.4+30.6 (1.82%)

1656.90

1712.45

97,757Cr

2045+36 (1.79%)

1989.10

2061.55

92,007Cr

335-5 (-1.47%)

330

340

347Cr

Astonea Labs Share Price

330.00+0.00 (-2.94%)

+112.70% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year51%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-16%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year113%

Return on Equity

10 years21%

5 years21%

3 years21%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	51%
-	-	-	-16%
-	-	-	113%
21%	21%	21%	12%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

ASTONEALAB-M

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,771.95	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,030	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,635	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,320	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,239	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,370	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,392.2	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,477.1	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,699	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,012	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
330	₹357 Cr	79.15	2.95	9.04	₹5 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025
—	—
₹11 Cr	₹8 Cr
₹47 Cr	₹11 Cr
₹47 Cr	₹11 Cr
₹57 Cr	₹18 Cr
₹18 Cr	₹16 Cr
₹3 Cr	₹4 Cr
-₹55 L	₹3 L
₹8 L	₹0
₹43 L	₹33 L
₹21 Cr	₹20 Cr
—	—
₹40 Cr	₹26 Cr
₹8 Cr	₹8 Cr
₹19 Cr	₹29 Cr
₹2 Cr	₹2 Cr
₹69 Cr	₹65 Cr
₹147 Cr	₹104 Cr
₹4 Cr	₹9 Cr
₹43 Cr	₹53 Cr
—	—
₹31 Cr	₹26 Cr
₹31 Cr	₹26 Cr
₹8 Cr	₹4 Cr
₹6 Cr	₹0
₹6 Cr	₹0
₹30 L	₹29 L
₹2 Cr	₹2 Cr
₹48 Cr	₹33 Cr
—	—
₹34 Cr	₹29 Cr
₹52 Cr	₹38 Cr
₹18 L	₹9 L
₹84 L	₹33 L
₹13 Cr	₹4 Cr
₹100 Cr	₹71 Cr
₹30 Cr	₹6 Cr
₹147 Cr	₹104 Cr
₹54	₹24
₹54	₹24

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025
₹6 Cr	₹7 Cr
₹8 Cr	₹8 Cr
-₹24 Cr	-₹2 Cr
-₹10 Cr	₹13 Cr
-₹14 Cr	₹9 Cr
-₹20 Cr	-₹11 Cr
₹34 Cr	₹2 Cr
₹9 L	-₹27 L
₹9 L	₹36 L
₹18 L	₹9 L

Fundamental Ratios

Consolidated

Standalone

No results found

Astonea Labs Share Price

330.00+0.00 (-2.94%)

+112.70% past 1 Year

Shareholding summary

Promoters

72.44%

FII

DII

Others

27.56%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Mar 2026	Sep 2025
72.44%	72.30%	72.30%
0.00%	0.00%	2.51%
0.00%	0.07%	0.35%
0.00%	0.00%	0.00%
27.56%	27.63%	24.84%

Bulk & block deals

Name

Swati Agarwala

Nu Heights Agency Private Limited

Padmawati Realcon Private Limited

Vivekgujrani

Basan Equity Broking Limited

Vivekgujrani

Caravan Properties Private Limited

Astorne Capital Vcc Arven

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
07 May 2026	Sell	1.11 Cr	₹168.78	66 K	Bulk	0.627914	BSE
06 May 2026	Sell	1.74 Cr	₹166	1.05 L	Bulk	0.998953	BSE
26 Nov 2025	Purchase	1.35 Cr	₹149.59	90 K	Bulk	0.856246	BSE
26 Nov 2025	Purchase	1.05 Cr	₹150.41	70 K	Bulk	0.665969	BSE
24 Nov 2025	Purchase	7 L	₹139.99	5 K	Bulk	0.047569	BSE
24 Nov 2025	Sell	64.11 L	₹118.73	54 K	Bulk	0.513748	BSE
12 Nov 2025	Sell	75.61 L	₹140.02	54 K	Bulk	0.513748	BSE
03 Jun 2025	Purchase	6.48 Cr	₹137.58	4.71 L	Bulk	4.48102	BSE
03 Jun 2025	Purchase	85.27 L	₹137.53	62 K	Bulk	0.589858	BSE
03 Jun 2025	Sell	1.17 Cr	₹137.49	85 K	Bulk	0.808677	BSE

Insider trading & SAST

Client name

Ashish Gulati

Vivek Gujrani

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
17 Sep 2026	Promoter	Acquisition	0.028542	70.94	9.40 L	₹313.50	3 K	16 Sep 2026	Market Purchase	74,56,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.87	2.98 L	₹298.50	1 K	16 Sep 2026	Market Purchase	74,48,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.92	3.13 L	₹313	1 K	16 Sep 2026	Market Purchase	74,53,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.028542	70.85	8.91 L	₹297	3 K	16 Sep 2026	Market Purchase	74,46,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.019028	70.9	6.20 L	₹310	2 K	16 Sep 2026	Market Purchase	74,51,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.91	3.12 L	₹312	1 K	16 Sep 2026	Market Purchase	74,52,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.88	3 L	₹299.50	1 K	16 Sep 2026	Market Purchase	74,49,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.82	2.85 L	₹285	1 K	15 Sep 2026	Market Purchase	74,43,970	Insider Trading	—	Equity
17 Sep 2026	Promoter	Acquisition	0.009514	70.86	2.98 L	₹297.50	1 K	16 Sep 2026	Market Purchase	74,47,970	Insider Trading	—	Equity
05 Jul 2025	Other	Acquisition	5.64	5.64	0	—	5.93 L	03 Jun 2025 - 13 Jun 2025	Market	5,93,000	SAST	29(1)	—

Astonea Labs Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Astonea Labs Share Price

Astonea Labs Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Astonea Labs Share Price

Astonea Labs Share Price

Oscillators

Moving averages

Astonea Labs Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Astonea Labs Share Price

Corporate Actions

Company details

Astonea Labs Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Astonea Labs Share Price

News

Astonea Labs informs about fire incident at manufacturing facility

Astonea Labs informs about updates

Astonea Labs incorporates wholly owned subsidiary in USA

Astonea Labs informs about resignation of CS cum CO

Astonea Labs informs about resignation of CS cum CO

Astonea Labs Ltd Share Price Today

Astonea Labs Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator